arrow
R

Róbert Wágner

Heinrich-Heine-University Dusseldorf
H指数:46
被引数:8,327

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiometabolic traits at hospital admission impact on outcome in STEMI: insights from the prospective SYSTEMI Trial in completely revascularized patients

STEMI患者入院时的心血管代谢特征对预后的影响:来自完全血管重建患者的SYSTEMI前瞻性试验的见解

2026-11-130
OAAI
Associations of long-term exposure to air pollution with glucose homeostasis biomarkers and diabetes-related comorbidities in people with recent-onset type 1 and type 2 diabetes

长期空气污染暴露与近期发生1型和2型糖尿病患者血糖稳态生物标志物及糖尿病相关并发症的关联

2026-11-050
OAAI
International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG

Vujasinovic, M.; Demir, I.E.; Marchegiani, G.; Hegyi, P.; Archibugi, L.; Valente, R.; Capurso, G.; Witt, H.; Bonovas, S.; Piovani, D.; 等. 国际多学科共识报告:关于脂肪性胰腺的定义、诊断标准和管理——一项由EPC、APA、EASD、EASL、ESGAR、ESGE、ESP、ESPCG、ESPEN、ESPGHAN、IAP、JPS、KPBA、LAPSG和UEG联合声明的报告. United Eur. Gastroenterol. J. 2026, 14, e70185. [Google Scholar] [CrossRef] [PubMed]

2026-02-140
OAAI
Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes

基于可解释AI的分析对人类胰腺切片进行研究,识别出了2型糖尿病的特征

2026-02-090
OAAI
PTA-DFS study: design of a randomised controlled trial assessing the effects of early percutaneous transluminal angioplasty on the healing of diabetic foot ulcers in persons with type 2 diabetes

PTA-DFS研究:一项随机对照试验的设计,评估早期经皮腔内血管成形术对2型糖尿病患者的糖尿病足溃疡愈合的影响

2025-11-140
OAAI
Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana

临床诊断的1型糖尿病中的异质性:表征一个在加纳维持C肽分泌的独特队列

2025-11-010
OA
Prevention of type 2 diabetes through prediabetes remission without weight loss

通过糖尿病前期缓解而非体重减轻来预防2型糖尿病

2025-09-290
OAAI
Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes

肥胖手术对2型糖尿病风险个体的亚表型依赖性益处

2025-04-110
PRE